We developed a model of pulmonary sepsis-induced ARDS in pigs that had long-lasting features consistent with human ARDS. Our model was characterized by the following aspects: (I) development of severe oxygenation disorders; (II) development of hypercapnia despite the application of high-minute ventilation (reflecting an increase in dead-space ventilation); (III) decrease in respiratory system static compliance; (IV) increase in pulmonary permeability; (V) presence of cardiovascular dysfunction (sepsis-induced vasoplegia); (VI) pulmonary and systemic inflammation; and (VII) signs of diffuse alveolar damage.
The model presented fulfills recent recommendations for animal experimentation in the field of acute lung injury [
16]. That considered, we demonstrated histological evidence of tissue injury; alteration of the alveolar–capillary barrier; presence of systemic and pulmonary inflammatory response; and severe respiratory dysfunction. Furthermore, other relevant characteristics specific to the model should be underscored: First and foremost, the pulmonary insult used in the induction period is the main cause of ARDS in humans (bacterial pneumonia). Moreover, the second hit used in the model (VILI) might be unavoidable in human ARDS, as ventilation with high strain and stress is needed to maintain gas exchange in the most severe patients [
6]. Second, the large duration of the experiment allows for tracking changes in respiratory physiology. Third, large animals allow for advanced monitoring (i.e., electrical impedance tomography, and analysis of chest wall and pulmonary respiratory mechanics, pulmonary and systemic hemodynamics, etc.) as well as evaluation of complex therapies such as extracorporeal membrane oxygenation and mechanical ventilation.
Comparison of animal models and their characteristics
Given the clinically relevant insults used (pneumonia and VILI) as well as the physiological characteristics exhibited during the 96-h experiment period, we believe that the model presented has higher accuracy in reproducing human ARDS compared with others [
7,
8,
16,
17].
In line with our study, the repeated lavage model presents remarkable gas exchange disorders and diminished compliance due to surfactant depletion. Specifically, our ARDS model shows a mean PaO
2/FiO
2 which, throughout the model development, ranges in moderate severity with periods of severe instability. Moreover, notably diminished and progressively deteriorating compliance is found throughout the model development period as well. Surfactant depletion is not the main mechanism of respiratory failure in adult ARDS; hence, this model fails to reproduce other clinical features of ARDS. For example, in contrast from our model, only modest epithelial injury signs are present; permeability changes, scarce; and clinical features described, reversible, lasting less than 24 h [
9,
10,
18]. Our model, however, presents a histology that demonstrates that severe epithelial damage and disorders in oxygenation are maintained up to approximately 60 h. In the surfactant depletion model, some authors reported an increase in BAL cytokines, but the role of inflammation is unclear [
9]. We demonstrated, nonetheless, an increase in both systemic and pulmonary inflammation and signs of sepsis-associated cardiovascular dysfunction.
Similar flaws are identified in the oleic acid (OA) model. This one mimic ARDS caused by fat embolism, an exceptional etiology of syndrome [
10]. In the OA model, the pathophysiology of pulmonary injury is unknown and unlikely similar to the most common causes of ARDS such as pneumonia, the risk factor used in our model [
6]. OA administration raises pulmonary arterial pressure and intrapulmonary shunt [
19‐
21] and produces a marked increase in EVLW [
20]. We also showed a rise in the mean pulmonary arterial pressure and EVLW. We tracked changes in PaO
2/FiO
2 as surrogate of pulmonary shunt, identifying periods with a value below 100 mmHg (i.e., severe ARDS). In the OA model, an inflammatory response is shown with an increase in some inflammatory markers in lung such as IL-6 and IL-1 beta [
22‐
24]. At histological examination, however, only mild signs of lung injury are found with no hyaline membrane formation [
20,
23,
25]. In our model, though, we demonstrated DAD in 83% of histological specimens of pigs with ARDS. In the OA model, the severity of lung injury is somewhat unpredictable because animals present different responses per OA doses and sudden, intense hemodynamic instability during infusion [
23,
25]. Like the repeated lavage model, the oleic acid-induced lung injury is also reversible within several hours, contrasting with our 60-h ARDS period [
21,
23].
Systemic administration of bacterial lipopolysaccharides (LPS) was one of the earliest approaches used to study sepsis-induced ARDS. LPS administration markedly decreases PaO
2 and systemic arterial pressure. It also provides important information about host inflammatory responses in BAL and serum [
7,
26]. For that reason, it is a good choice for pathophysiological studies of infection and ARDS [
7,
26]. Our model follows this approach; however, we instill viable bacteria—rather than bacterial toxins—into the lungs, thus fulfilling the complete clinical picture of severe pneumonia. During the model development, a high burden of
P. aeruginosa was found in BAL and tracheal aspirates. While we did not find differences in BAL samples, we did identify a lower bacterial burden in tracheal aspirates from animals with ARDS in comparison with those who did not develop it. The interpretation of this finding is not clear. We speculate that the plasma leak into the lungs of pigs with ARDS prompted tracheal aspirations more frequently and promoted bacterial clearance. Histological alterations observed in the LPS model are mainly neutrophil parenchymal infiltration and mild edema, features that resemble those seen in pneumonia. However, in this model, hyaline membranes are lacking [
7,
27], suggesting milder epithelial damage and lower pulmonary permeability compared with our model. Other limitations of this model are short duration, significant differences in endotoxin response between species and variability in biological activity of endotoxin preparations [
8]. In contrast, the duration of our model is enough to perform multiple analyses, given its reproducible nature as well.
The smoke/burn is a reproducible model that resembles the clinical time course of ARDS during the first 24 h. It can be used in studies up to 96 h [
28]. However, smoke inhalation as etiology of ARDS is not frequent, and the pathophysiology of lung injury is different from sepsis [
6]. Although some studies achieve severe respiratory failure [
28], this does not last longer 24 h [
29,
30]. Inflammatory markers as IL-6 are found elevated in BAL and plasma [
28,
31]. Histology observations demonstrate a presence of inflammatory infiltrate, mild hemorrhage and edema, albeit no hyaline membranes [
28,
31,
32].
Injurious ventilation has been used as a unique or double-hit model to reproduce ARDS in animals [
8,
32]. In rodent animal models, VILI causes an impairment in respiratory mechanics [
33,
34], tissue injury [
33,
35] and pulmonary permeability [
34], but oxygenation disorders are mild and do not usually meet ARDS criteria [
36‐
39]. These findings in small animals are difficult to translate in terms of humans. Contrarily, in larger animal models, VILI provokes severe respiratory failure. Unlike our model, though, it does not last longer than 24 h [
38‐
42]. In these models, inflammation caused by VILI was also evaluated by several methods including cytokine analysis in BAL fluid, plasma and lung tissue, and either immunohistochemistry or immunofluorescence [
8,
33-
44]. While some studies confirmed that VILI induces a pulmonary inflammatory response [
33‐
39], others did not [
44]. These differences might be explained by either the intensity of VILI observed between studies or the primary pulmonary insult performed before aggressive ventilation was started [
45]. Interpretations of our findings should consider that we used a DP of up to 30 cmH
2O to ensure a clinically significant pulmonary strain and that such ventilation was performed in lungs affected by a primary inflammatory insult (pneumonia). Interestingly, as observed in our model, other authors reported the presence of hyaline membranes and diffuse alveolar damage in animals ventilated in an injurious fashion [
40].
The effect of ventilator-induced lung injury in pneumonia
In our model, the group with low pulmonary strain—no VILI—presented oxygen disorders that were mild and did not meet the Berlin criteria for ARDS. On the other hand, pigs comprising the pneumonia-with-VILI group had sustained life-threatening gas exchange disorders, as well as other remarkable disturbances. In the current model, however, we did not find clinically relevant extrapulmonary organ dysfunctions other than hemodynamic failure (sepsis-induced vasoplegia). The latter was more prominent in the pneumonia-with-VILI group. Of note, while pigs with ARDS exhibited a high inflammatory response, this was not clearly influenced by the presence of VILI during model development. Importantly, high mortality (33.3%) found only in the group of pigs ventilated with the high pulmonary strain was driven by respiratory acidosis and refractory respiratory failure.
The findings described between groups merit clinical interpretation. Refractory respiratory failure—either manifested as severe hypoxemia or respiratory acidosis—represents a non-negligible cause of death and morbidity in ARDS [
46,
47]. Given the extreme oxygenation and ventilation disorders found in the group of pigs with VILI, maintaining protective ventilation was challenging after the ARDS diagnosis (model development period). This is revealed by an increase in mechanical power throughout all the experiment which, consequently, might have dramatically diminished the chances of pulmonary recovery in the group with VILI. Our results, therefore, suggest that a high pulmonary strain might ease progression to ARDS in pneumonia and perhaps raise respiratory-attributable death.
Limitations
Some limitations are present in this study. First, as a result of severe respiratory failure, mortality reported in this model was high (33.3%). Second, we only studied ten non-randomized pigs and just those treated with high pulmonary strain fulfilled the diagnostic criteria for ARDS. Nevertheless, the dispersion of data was low, and our findings were consistent. Due to logistical constraints, animals were not randomized. Third, critically ill patients usually present with significant comorbidities that determine prognosis. However, animals used in the model were female, young and healthy. Moreover, the sequence of events in the clinical setting differs, as patients initially experience an insult that results in respiratory insufficiency, followed by the need for mechanical ventilation. In our model, healthy animals underwent injurious ventilation, were then subjected to bacterial challenge and finally continued to receive injurious ventilation. Fourth, P. aeruginosa is a cause of pneumonia in patients with specific risk factors such as airway diseases (i.e., chronic obstructive pulmonary disease) and immunosuppression. Fifth, there was not a control group of pigs without pneumonia that received treatment with aggressive ventilation.